BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31137455)

  • 1. Thrombin Preconditioning Enhances Therapeutic Efficacy of Human Wharton's Jelly-Derived Mesenchymal Stem Cells in Severe Neonatal Hypoxic Ischemic Encephalopathy.
    Kim YE; Sung SI; Chang YS; Ahn SY; Sung DK; Park WS
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical assessment of thrombin-preconditioned human Wharton's jelly-derived mesenchymal stem cells for neonatal hypoxic-ischaemic brain injury.
    Noh JH; Jeong JS; Park SJ; Jin Jung K; Lee BS; Kim WJ; Han JS; Cho MK; Sung DK; Ahn SY; Chang YS; Son HY; Jeong EJ
    J Cell Mol Med; 2021 Nov; 25(22):10430-10440. PubMed ID: 34651412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin Preconditioning Improves the Therapeutic Efficacy of Mesenchymal Stem Cells in Severe Intraventricular Hemorrhage Induced Neonatal Rats.
    Jung SY; Kim YE; Park WS; Ahn SY; Sung DK; Sung SI; Joo KM; Kim SG; Chang YS
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin Priming Promotes the Neuroprotective Effects of Human Wharton's Jelly-Derived Mesenchymal Stem Cells Via the HGF/AKT/STAT3 Signaling Pathway.
    Ha GH; Yeon JY; Kim KH; Lee DM; Chae HY; Nam H; Lee K; Kim DO; Kim CK; Joo KM
    Stem Cells Dev; 2024 Feb; 33(3-4):89-103. PubMed ID: 38164089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothermia augments neuroprotective activity of mesenchymal stem cells for neonatal hypoxic-ischemic encephalopathy.
    Park WS; Sung SI; Ahn SY; Yoo HS; Sung DK; Im GH; Choi SJ; Chang YS
    PLoS One; 2015; 10(3):e0120893. PubMed ID: 25816095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothermia broadens the therapeutic time window of mesenchymal stem cell transplantation for severe neonatal hypoxic ischemic encephalopathy.
    Ahn SY; Chang YS; Sung DK; Sung SI; Park WS
    Sci Rep; 2018 May; 8(1):7665. PubMed ID: 29769612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BDNF-Overexpressing Engineered Mesenchymal Stem Cells Enhances Their Therapeutic Efficacy against Severe Neonatal Hypoxic Ischemic Brain Injury.
    Ahn SY; Sung DK; Chang YS; Sung SI; Kim YE; Kim HJ; Lee SM; Park WS
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wharton's Jelly-Derived Mesenchymal Stem Cell Transplantation in a Patient with Hypoxic-Ischemic Encephalopathy: A Pilot Study.
    Kabataş S; Civelek E; İnci Ç; Yalçınkaya EY; Günel G; Kır G; Albayrak E; Öztürk E; Adaş G; Karaöz E
    Cell Transplant; 2018 Oct; 27(10):1425-1433. PubMed ID: 30203688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human pluripotent stem cell-derived ectomesenchymal stromal cells promote more robust functional recovery than umbilical cord-derived mesenchymal stromal cells after hypoxic-ischaemic brain damage.
    Huang J; U KP; Yang F; Ji Z; Lin J; Weng Z; Tsang LL; Merson TD; Ruan YC; Wan C; Li G; Jiang X
    Theranostics; 2022; 12(1):143-166. PubMed ID: 34987639
    [No Abstract]   [Full Text] [Related]  

  • 10. The neuroprotective effect of mesenchymal stem cells is mediated through inhibition of apoptosis in hypoxic ischemic injury.
    Li F; Zhang K; Liu H; Yang T; Xiao DJ; Wang YS
    World J Pediatr; 2020 Apr; 16(2):193-200. PubMed ID: 31535281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between the effect of human Wharton's jelly-derived mesenchymal stem cells and levetiracetam on brain infarcts in rats.
    Abd El Motteleb DM; Hussein S; Hasan MM; Mosaad H
    J Cell Biochem; 2018 Dec; 119(12):9790-9800. PubMed ID: 30171723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effect of human umbilical cord mesenchymal stem cells on neonatal rat hypoxic-ischemic encephalopathy.
    Zhang X; Zhang Q; Li W; Nie D; Chen W; Xu C; Yi X; Shi J; Tian M; Qin J; Jin G; Tu W
    J Neurosci Res; 2014 Jan; 92(1):35-45. PubMed ID: 24265136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. hUC-MSCs Exert a Neuroprotective Effect via Anti-apoptotic Mechanisms in a Neonatal HIE Rat Model.
    Xu J; Feng Z; Wang X; Xiong Y; Wang L; Ye L; Zhang H
    Cell Transplant; 2019 Dec; 28(12):1552-1559. PubMed ID: 31512502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Placenta-Derived Mesenchymal Stem Cells Improve Neurological Function in Rats with Intrauterine Hypoxic-Ischaemic Encephalopathy by Reducing Apoptosis and Inflammatory Reactions.
    Zhao YQ; Xu YY; Zheng YM; Han F; Zhang Y; Pan RL; Chen JR; Hao YM; Yang LW
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):139. PubMed ID: 38682178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Treatment with Stem Cells from Human Exfoliated Deciduous Teeth for Hypoxic-Ischemic Encephalopathy in Neonatal Rats.
    Kitase Y; Sato Y; Ueda K; Suzuki T; Mikrogeorgiou A; Sugiyama Y; Matsubara K; Tsukagoshi Okabe Y; Shimizu S; Hirata H; Yukawa H; Baba Y; Tsuji M; Takahashi Y; Yamamoto A; Hayakawa M
    Stem Cells Dev; 2020 Jan; 29(2):63-74. PubMed ID: 31801412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia/Reoxygenation-Preconditioned Human Bone Marrow-Derived Mesenchymal Stromal Cells Rescue Ischemic Rat Cortical Neurons by Enhancing Trophic Factor Release.
    Kim YS; Noh MY; Cho KA; Kim H; Kwon MS; Kim KS; Kim J; Koh SH; Kim SH
    Mol Neurobiol; 2015 Aug; 52(1):792-803. PubMed ID: 25288154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxic preconditioning improves the survival and neural effects of transplanted mesenchymal stem cells via CXCL12/CXCR4 signalling in a rat model of cerebral infarction.
    Hu Y; Chen W; Wu L; Jiang L; Qin H; Tang N
    Cell Biochem Funct; 2019 Oct; 37(7):504-515. PubMed ID: 31368195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxic Preconditioning Enhances the Efficacy of Mesenchymal Stem Cells-Derived Conditioned Medium in Switching Microglia toward Anti-inflammatory Polarization in Ischemia/Reperfusion.
    Yu H; Xu Z; Qu G; Wang H; Lin L; Li X; Xie X; Lei Y; He X; Chen Y; Li Y
    Cell Mol Neurobiol; 2021 Apr; 41(3):505-524. PubMed ID: 32424775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cell therapy for intractable neonatal disorders.
    Ahn SY; Park WS; Sung SI; Chang YS
    Pediatr Neonatol; 2021 Feb; 62 Suppl 1():S16-S21. PubMed ID: 33485822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethionamide Preconditioning Enhances the Proliferation and Migration of Human Wharton's Jelly-Derived Mesenchymal Stem Cells.
    Lee NH; Myeong SH; Son HJ; Hwang JW; Lee NK; Chang JW; Na DL
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.